NCT04080622View on ClinicalTrials.gov

Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation.

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

October 8, 2023

Study Completion Date

October 31, 2023

Conditions

Mucositis OralStem Cell Transplant Complications

Interventions

DRUG

Selenium

Selenium 300 µg/day (IV infusion)

DRUG

Placebos

NaCl 0,9% (IV infusion)

Trial Locations (1)

49933

CHU Angers, Angers

All Listed Sponsors

lead

University Hospital, Angers

OTHER_GOV

NCT04080622 - Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation. | Biotech Hunter | Biotech Hunter